Recommendations Summary
DM: Protein Intake and Protein Intake for Diabetic Kidney Disease (DKD) (2015)
Click here to see the explanation of recommendation ratings (Strong, Fair, Weak, Consensus, Insufficient Evidence) and labels (Imperative or Conditional). To see more detail on the evidence from which the following recommendations were drawn, use the hyperlinks in the Supporting Evidence Section below.
-
Recommendation(s)
DM: Educate on Protein Intake and Hypoglycemia in Adults with Diabetes
The registered dietitian nutritionist (RDN) should educate adults with diabetes that adding protein to meals and snacks does not prevent or assist in the treatment of hypoglycemia. Ingested protein appears to increase insulin response without increasing plasma glucose concentrations; therefore, carbohydrate sources high in protein should not be used to treat or prevent hypoglycemia.
Rating: Fair
ImperativeDM: No Protein Restriction for Diabetic Kidney Disease (DKD)
For adults with diabetes and diabetic kidney disease (DKD), the registered dietitian nutritionist (RDN) does not need to prescribe a protein restriction. While research reports mixed results regarding the effects of the amount of protein on fasting glucose levels and A1C, independent of weight loss, in adults with type 1 diabetes and type 2 diabetes and DKD, there was no significant impact of protein intake (ranging from 0.7g to 2.0g per kg per day) on GFR.
Rating: Strong
ConditionalDM: Type of Protein and Diabetic Kidney Disease (DKD)
The registered dietitian nutritionist (RDN) should advise adults with type 2 diabetes and diabetic kidney disease (DKD) that the type of protein (vegetable-based vs.animal-based) will not have a significant effect on GFR. However, there may be an effect on fasting glucose levels and proteinuria. While one study reports a positive impact of soy protein compared to animal protein on proteinuria and fasting glucose levels, independent of weight loss, in adults with type 2 diabetes and DKD, there was no significant impact of soy protein consumption on GFR.
Rating: Weak
Conditional-
Risks/Harms of Implementing This Recommendation
None.
-
Conditions of Application
The recommendations DM: No Protein Restriction for Diabetic Kidney Disease (DKD) and DM: Type of Protein and Diabetic Kidney Disease (DKD) apply to adults with diabetes and diabetic kidney disease (DKD).
-
Potential Costs Associated with Application
Costs of MNT sessions and reimbursement vary; however, MNT sessions are essential for improved outcomes.
-
Recommendation Narrative
- Research reports mixed results regarding the effects of the amount of protein (ranging from 0.8g to 2.0g per kg per day) on fasting glucose levels and A1C, independent of weight loss, in adults with type 1 diabetes and type 2 diabetes and diabetic kidney disease (Raal et al, 1994; Hansen et al, 2002; Velazquez et al, 2008). Grade III
- Research reports that the amount of protein (ranging from 0.7g to 2.0g per kg per day) had no effect on GFR, independent of weight loss, in adults with type 1 diabetes and type 2 diabetes and diabetic kidney disease. No studies reported on proteinuria (Robertson et al, 2007; Velazquez et al, 2008). Grade I
- There were no studies identified regarding the relationship of differing amounts of protein, independent of weight loss, on insulin levels (exogenous/endogenous) in adults with type 1 diabetes and type 2 diabetes. Intervention studies are needed regarding the impact of differing amounts of protein on insulin levels in adults with diabetes. Grade V
- One study reports a positive impact of soy protein compared to animal protein on proteinuria, independent of weight loss, in adults with type 2 diabetes and diabetic kidney disease (Azadbakht et al, 2008). There was no significant impact of soy protein consumption on glomerular filtration rate. There were no studies identified in adults with type 1 diabetes. Additional intervention studies are needed regarding the impact of differing types of protein on diabetic kidney disease in adults with diabetes. Grade III
- One study reports a positive impact of soy protein compared to animal protein on fasting glucose levels, independent of weight loss, in adults with type 2 diabetes and diabetic kidney disease (Azadbakht et al, 2008). No studies were identified that reported on A1C or that included adults with type 1 diabetes. Additional intervention studies are needed regarding the impact of differing types of protein on glycemia in adults with diabetes. Grade III
- There were no studies identified regarding the relationship of differing types of protein (vegetable-based vs. animal-based), independent of weight loss, on insulin levels (exogenous/endogenous) in adults with type 1 diabetes and type 2 diabetes. Intervention studies are needed regarding the impact of differing types of protein on insulin levels in adults with diabetes. Grade V
From the 2013 American Diabetes Association Nutrition Therapy Recommendations
- For people with diabetes and no evidence of diabetic kidney disease, evidence is inconclusive to recommend an ideal amount of protein intake for optimizing glycemic control or improving one or more CVD risk measures; therefore, goals should be individualized. Grade C
- For people with diabetes and diabetic kidney disease (either microalbuminuria or macroalbuminuria), reducing the amount of dietary protein below usual intake is not recommended because it does not alter glycemic measures, cardiovascular risk measures, or the course of GFR decline. Grade A
- In individuals with type 2 diabetes, ingested protein appears to increase insulin response without increasing plasma glucose concentrations. Therefore, carbohydrate sources high in protein should not be used to treat or prevent hypoglycemia. Grade B
From the 2015 American Diabetes Association Standards of Medical Care in Diabetes
In individuals with type 2 diabetes, ingested protein appears to increase insulin response without increasing plasma glucose concentrations. Therefore, carbohydrate sources high in protein should not be used to treat or prevent hypoglycemia. Grade B
Foundations of Care: Education, Nutrition, Physical Activity, Smoking Cessation, Psychosocial Care and ImmunizationMicrovascular Complications and Foot Care
For people with diabetic kidney disease, reducing the amount of dietary protein below the recommended daily allowance of 0.8g per kg per ay (based on ideal body weight) is not recommended because it does not alter glycemic measures, cardiovascular risk measures or the course of GFR decline. Grade A -
Recommendation Strength Rationale
- Conclusion Statements in support of these recommendations were given Grades I, III and V
- The 2013 American Diabetes Association Nutrition Therapy Recommendations received Grades A, B and C
- The 2015 American Diabetes Association Standards of Medical Care in Diabetes received Grades A and B.
-
Minority Opinions
Consensus reached.
-
Risks/Harms of Implementing This Recommendation
-
Supporting Evidence
The recommendations were created from the evidence analysis on the following questions. To see detail of the evidence analysis, click the blue hyperlinks below (recommendations rated consensus will not have supporting evidence linked).
In adults with type 1 and type 2 diabetes, what is the relationship of differing amounts of protein, independent of weight loss, on glycemia (A1C or glucose)?
In adults with type 1 and type 2 diabetes, what is the relationship of differing amounts of protein, independent of weight loss, on diabetic kidney disease (GFR and/or proteinuria)?
In adults with type 1 and type 2 diabetes, what is the relationship of differing amounts of protein, independent of weight loss, on insulin levels (exogenous/endogenous)?
In adults with type 1 and type 2 diabetes, what is the relationship of differing types of protein (vegetable-based versus animal-based), independent of weight loss, on diabetic kidney disease (GFR and/or proteinuria)?
In adults with type 1 and type 2 diabetes, what is the relationship of differing types of protein (vegetable-based vs. animal-based), independent of weight loss, on glycemia (A1C or glucose)?
In adults with type 1 and type 2 diabetes, what is the relationship of differing types of protein (vegetable-based versus animal-based), independent of weight loss, on insulin levels (exogenous/endogenous)?-
References
Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008; 31(4): 648-654.
Hansen HP, Tauber-Lassen E, Jensen BR, Parving H-H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002:61:220-228.
Raal FJ, Kalk WJ, Lawson M, Esser JD, Buys R, Fourie L, Panz VR. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-month prospective study. Am J Clin Nutr. 1994;60:579-585.
Velázquez LL, Sil AMJ, Goycochea RMV, Torres TM, Castañeda LR. Effect of protein restriction diet on renal function and metabolic control in patients with type 2 diabetes: A randomized clinical trial. Nutr Hosp. 2008; 23: 141-147.
Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007; 4: CD002181. -
References not graded in Academy of Nutrition and Dietetics Evidence Analysis Process
American Diabetes Association. Standards of medical care in diabetes–2015. Diabetes Care. 2015; 38(1): S1-S94.
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy Jr WS. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013; 36: 3, 821-3, 841.
-
References